AI assistant
Vericel Corp — Director's Dealing 2021
Jan 26, 2021
31799_dirs_2021-01-26_47547f12-c654-4375-bc74-72f901b62685.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2021-01-25
Reporting Person: Mara Joseph Anthony Jr (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-25 | Stock Option (right to buy) | $43.63 | A | 150832 | Acquired | 2031-01-25 | Common Stock (150832) | Direct |
| 2021-01-25 | Restricted Stock Unit | $ | A | 16000 | Acquired | Common Stock (16000) | Direct | |
| 2021-01-25 | Stock Option (right to buy) | $43.63 | A | 9168 | Acquired | 2031-01-25 | Common Stock (9168) | Direct |
Footnotes
F1: These options shall begin vesting on January 25, 2021 and shall vest and become exercisable on January 25, 2022, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter.
F2: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
F3: These RSUs vest in four equal installments with the initial vesting of RSUs granted to the Reporting Person on March 31, 2021. The remaining RSUs will vest on June 30, 2021, September 30, 2021, and December 31, 2021, respectively.
F4: No expiration date for this type of award.